跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bdgef - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Bdgef
Approved
STANDARD
Bdgef
BDR Pharmaceuticals International Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8c8560ffdb794a4f
Company
BDR Pharmaceuticals International Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
8c8560ffdb794a4f
Drug Approval Philippines Name
Bdgef
Product Name
Bdgef
Registration Number
DR-XY44770
Brand Name
Bdgef
Generic Name
Gefitinib
Dosage Form
Film-Coated Tablet
Dosage Strength
250 mg
Manufacturer
BDR Pharmaceuticals International Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
27 May 2022
Expiry Date
28 August 2025
Pharmacologic Category
Antineoplastic (Protein Kinase Inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8c8560ffdb794a4f
Type
Standard
Back to Philippines FDA Approvals